Literature DB >> 24934779

Epidermal Growth Factor Receptor P753S Mutation in Cutaneous Squamous Cell Carcinoma Responsive to Cetuximab-Based Therapy.

Prasanth Ganesan1, Siraj M Ali2, Kai Wang2, George R Blumenschein1, Bita Esmaeli1, Robert A Wolff1, Vincent A Miller2, Phillip J Stephens2, Jeffery S Ross2, Gary A Palmer2, Filip Janku3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24934779     DOI： 10.1200/JCO.2013.50.3516

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  High-throughput functional evaluation of human cancer-associated mutations using base editors.

Authors:  Younggwang Kim; Seungho Lee; Soohyuk Cho; Jinman Park; Dongwoo Chae; Taeyoung Park; John D Minna; Hyongbum Henry Kim
Journal:  Nat Biotechnol       Date:  2022-04-11       Impact factor: 68.164

2.  Comparison of uncommon EGFR exon 21 L858R compound mutations with single mutation.

Authors:  Liang Peng; Zhigang Song; Shunchang Jiao
Journal:  Onco Targets Ther       Date:  2015-04-21       Impact factor: 4.147

3.  A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review.

Authors:  Xiaohu Xu; Dong Chen; Xiao Wu; Qi Wang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

4.  Molecular profiling of head and neck squamous cell carcinoma.

Authors:  Rebecca Feldman; Zoran Gatalica; Joseph Knezetic; Sandeep Reddy; Cherie-Ann Nathan; Nader Javadi; Theodoros Teknos
Journal:  Head Neck       Date:  2015-11-28       Impact factor: 3.147

5.  Multiplexed molecular profiling of lung cancer with malignant pleural effusion using next generation sequencing in Chinese patients.

Authors:  Xingya Ruan; Yonghua Sun; Wei Wang; Jianwei Ye; Daoyun Zhang; Ziying Gong; Mingxia Yang
Journal:  Oncol Lett       Date:  2020-03-05       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.